NCT00165776View on ClinicalTrials.gov

Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Dose-Response, Study of E2014 in Patients WIth Spasmodic Torticollis

PHASE2CompletedINTERVENTIONAL
Enrollment

133

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

May 31, 2006

Study Completion Date

November 30, 2006

Conditions
Cervical DystoniaSpasmodic Torticollis
Interventions
DRUG

BOTULINUM TOXIN TYPE B

Trial Locations (21)

290-0003

Ichihara

807-0804

Kitakyushu

060-0061

Sapporo

060-0814

Sapporo

890-0075

Kagoshima

216-0015

Kawasaki

228-0829

Sagamihara

601-1434

Kyoto

390-0802

Matsumoto

634-0813

Kashihara

570-0074

Moriguchi

553-0003

Osaka

590-0132

Sakai

338-0002

Saitama

338-0003

Saitama

359-1141

Tokorozawa

430-0906

Hamamatsu

770-0042

Tokushima

113-0033

Bunkyo-ku

153-0044

Meguro-ku

162-0054

Shinjuku-ku

All Listed Sponsors
lead

Eisai Co., Ltd.

INDUSTRY

NCT00165776 - Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Dose-Response, Study of E2014 in Patients WIth Spasmodic Torticollis | Biotech Hunter | Biotech Hunter